ATLANTA (CN) — A federal appeals court on Monday rejected a pharmaceutical company’s motion for relief from a $40 million contempt judgement to the Federal Trade Commission for making repeated false ...
Co announces the FDA granted tentative approval to the co's Abbreviated New Drug Application for Calcipotriene topical solution, 0.005%. Hi-Tech's Calcipotriene topical solution is the generic ...
Co announces it entered into a settlement and release agreement regarding the patent infringement suit brought by MedPointe Pharmaceuticals related to Hi-Tech's generic version of Tussi-12 DS, covered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results